To help you achieve your scientific goals,
Thermo Fisher Scientific has created its 2021 Chromatography Innovation Series to share innovations and solutions that will address your most complex analytical challenges. This Series has four topics spanning eight months with spotlights on the latest innovations, applications, information and research.
To kick off this Series, Thermo Fisher has unveiled the latest GC-MS innovations that will empower you to transform your gas chromatography and gas chromatography-mass spectrometry results. The presentations include ‘The Next Generation Orbitrap Mass Spectrometry Family for Every Analytical Lab’ by Professor Alexander Makarov, Thermo Fisher Scientific, ‘Efficiency Gains of GC Orbitrap in High Throughput and Sensitive Testing’ by David Haas, Eurofins GfA Lab Services GmbH and ‘Improvement of Sensitivity, Accuracy and Precision of Quantitative Data Through Automation’ by Gilberto Pintonello, Veritas S.p.A.
expected. the baby received relatively high doses of three hiv drugs soon after birth. hiv positive newborns get low doses of one or two drugs after birth. if other babies could be cured after 15 months on drugs that would be huge. now hiv positive babies take these drugs for life and they can be toxic. more studies need to be dub, but this case may have inadvertently paved the way for other babies to have a brighter future. now, on routine testing, they can t find hiv in this baby s body. under super duper sensitive testing, they found remnants of rna and dna from the virus, so doctors are saying she is functionally cured. soledad. thank you, elizabeth. in a couple of minutes, we ll talk to rowena sdwron, a